menopausal hormone therapy


Also found in: Dictionary, Wikipedia.

menopausal hormone therapy

References in periodicals archive ?
Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women's Health Initiative randomized trials.
Menopausal hormone therapy (MHT) is recommended not only to control vasomotor problems and atrophic changes in the patients with premature ovarian failure, but also to slowdown atherosclerosis, to decrease the risk from cardiovascular diseases, osteoporosis and, possibly, Alzheimer's disease [11, 12].
Menopausal hormone therapy and cancer risk [online article].
Among all women, those who had used menopausal hormone therapy had a higher risk (HR, 1.
The Kronos Early Estrogen Prevention Study (KEEPS) is the name of an unnecessary trial that was conducted by hormone enthusiasts after the WHI proved that the harms of menopausal hormone therapy (including increased risks of breast cancer, heart attacks, strokes, and dementia) outweighed its only disease prevention benefit--a reduced risk of fractures.
Gleason and her colleagues found no improvement in cognitive function with either formulation of menopausal hormone therapy.
Previous studies showed mixed findings of the effects of menopausal hormone therapy on cognition, largely depending on whether treatment was initiated early on or later in menopause.
The South African Menopause Society 2014 consensus position statement on menopausal hormone therapy [12] is a revision of their statement published in the SAMJ of May 2007.
Although many patients have no contraindications to menopausal hormone therapy, often the first thing they're prescribed is an off-label psychiatric medication to treat their hot flashes," says Dr.
2012) Menopausal Hormone Therapy is assoc, with having high blood pressure in postmenopausal women.
For more on the WHI study, guidelines for considering menopausal hormone therapy and its potential risks and benefits, visit http://www.
The analysis revealed that Wyeth used ghostwritten reviews and commentaries published in medical journals to promote unproven benefits and downplay harms of Prempro -- a brand of menopausal hormone therapy ( HT) -- and to cast competing therapies in a negative light.